[Event Announcement] Japan Management: “Low Probability of Survival in 20 Years” – Jiai Kai Chairman Imamura Discusses Hospital Management Crisis and Sustainability Strategy – PR TIMES

The statement by Jiai Kai Chairman Imamura, suggesting a "20-year" timeframe for the future of medical institutions.This is not merely a distant future scenario, but a pressing reality that compels medical institution managers, especially those facing succession issues, to develop urgent management strategies. The "low probability of survival in 20 years" pointed out by Chairman Imamura is likely rooted in structural challenges such as demographic shifts, advancements in medical technology, and evolving regional healthcare needs. Particularly for small to medium-sized hospitals and clinics supporting regional healthcare, adapting to these changes is crucial for management sustainability.

In the context of medical M&A and business succession, this "20-year" perspective can serve as a significant motivator to accelerate the consideration of third-party succession.By viewing M&A not just as a solution to individual issues like a lack of successors, but as a long-term business continuity strategy, it becomes possible to shift from options like "business closure" or "clinic shutdown" towards a more constructive "business succession." This allows for the creation of a path that maximizes the interests of multiple stakeholders, including securing transaction value, maintaining employee employment, and, most importantly, ensuring the continuity of healthcare services for local residents.

For medical institution managers and those facing succession challenges, the key takeaway is the importance of formulating business plans with a long-term "20-year" perspective.Use Chairman Imamura's remarks as an opportunity to reflect on your own institution's future vision and develop concrete sustainability strategies. To achieve this, it is essential for directors and chief physicians, starting around age 60, to begin succession planning or external collaboration (including M&A) within a 5-10 year timeframe. This will broaden options and lead to a more favorable succession. When considering third-party succession, early engagement with advisors possessing specialized expertise is indispensable.